Sam-A Pharm. Co., Ltd (KOSDAQ:009300)
South Korea flag South Korea · Delayed Price · Currency is KRW
16,140
+10 (0.06%)
At close: Feb 13, 2026

Sam-A Pharm. Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
6,3209,5519,0199,1767,98418,396
Short-Term Investments
38,10048,63861,63868,63845,63829,911
Trading Asset Securities
46,48318,4748,4473,197-16,048
Cash & Short-Term Investments
90,90376,66479,10481,01153,62364,354
Cash Growth
24.58%-3.08%-2.35%51.08%-16.68%28.90%
Accounts Receivable
15,12919,06022,59621,46618,03915,418
Other Receivables
1,9602,7943,0792,0251,2931,878
Receivables
17,76421,85425,67523,49119,33217,296
Inventory
18,14214,28313,01312,2449,34112,157
Prepaid Expenses
-135.22160.7671.1444.8847.44
Other Current Assets
250.16153.4638.3740.2713.9611.46
Total Current Assets
127,059113,089117,992116,85682,35593,866
Property, Plant & Equipment
39,78742,75040,51137,16440,18843,412
Long-Term Investments
58,04471,93961,36242,95760,43436,951
Other Intangible Assets
4,6924,1894,2954,3945,5376,276
Long-Term Deferred Tax Assets
201.63519.3980.271,041-578.59
Other Long-Term Assets
16,3466,8197,067786.49657.771,024
Total Assets
246,129248,734231,308203,198189,172182,106
Accounts Payable
3,1205,8305,0027,0403,7722,562
Accrued Expenses
-907.142,2291,74515.7411.05
Current Portion of Long-Term Debt
3,4174,5561,667-2,407-
Current Portion of Leases
1,7961,8351,8581,7251,7091,783
Current Income Taxes Payable
1,4143,7213,5424,3861,580348.9
Other Current Liabilities
6,5723,6596,8476,6625,1114,762
Total Current Liabilities
16,31820,50821,14521,55814,5949,468
Long-Term Debt
-2,2782,500--2,407
Long-Term Leases
3,1944,2215,645451,5093,015
Pension & Post-Retirement Benefits
135.1482.87---12
Long-Term Deferred Tax Liabilities
-18.2412.0512.05175.08-
Other Long-Term Liabilities
2,0741,6501,536964.81868.76917.34
Total Liabilities
21,72128,75830,83822,58017,14715,819
Common Stock
6,3706,3706,3706,3706,3706,370
Additional Paid-In Capital
14,41314,41314,41314,41314,41314,413
Retained Earnings
200,521196,482179,204160,354149,836147,812
Treasury Stock
-1,513-1,513-1,513-1,513-1,513-1,513
Comprehensive Income & Other
4,6164,2231,996992.922,917-795.91
Shareholders' Equity
224,408219,976200,470180,618172,024166,287
Total Liabilities & Equity
246,129248,734231,308203,198189,172182,106
Total Debt
8,40612,89011,6691,7705,6257,206
Net Cash (Debt)
82,49763,77467,43579,24147,99857,148
Net Cash Growth
32.80%-5.43%-14.90%65.09%-16.01%37.89%
Net Cash Per Share
13515.9810449.0211048.8512983.197864.249363.43
Filing Date Shares Outstanding
6.16.16.16.16.16.1
Total Common Shares Outstanding
6.16.16.16.16.16.1
Working Capital
110,74192,58196,84895,29867,76184,398
Book Value Per Share
36768.0936041.8632845.9729593.2828185.2627245.20
Tangible Book Value
219,716215,787196,175176,224166,488160,011
Tangible Book Value Per Share
35999.2835355.5732142.1928873.3227278.1026216.95
Land
-4,3464,3469,3439,3439,343
Buildings
-30,47230,47230,44530,44530,445
Machinery
-29,43524,79123,85624,14123,879
Construction In Progress
-1,8361,17445.734.034.03
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.